Medivir AB operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medivir AB with three other
companies in this sector in Sweden:
sales of 74.92 million Swedish Kronor [US$8.59 million]
Alligator Bioscience Ab
(58.24 million Swedish Kronor [US$6.68 million]
Bioinvent International AB
(71.28 million Swedish Kronor [US$8.17 million]
of which 100%
was Drug Development).
Sales fell dramatically in 2016:
Medivir AB reported sales of SEK 93.04 million (US$10.67 million)
December of 2016.
decrease of 85.9%
versus 2015, when the company's sales were SEK 657.89 million.